Juvenescence Ltd 4
4 · AgeX Therapeutics, Inc. · Filed Feb 8, 2023
Insider Transaction Report
Form 4
Juvenescence Ltd
10% Owner
Transactions
- Award
Warrant to Purchase Common Stock
2023-02-07+340,136→ 340,136 totalExercise: $0.73Exp: 2026-01-25→ Common Stock (340,136 underlying)
Footnotes (2)
- [F1]Warrants issued in connection with the draw of loan funds under a Secured Convertible Promissory Note between the issuer and the reporting person.
- [F2]The warrants are exercisable for shares of the issuer's common stock upon issuance.